1322 Cetuximab monotherapy and cetuximab plus capecitabine as first-line treatment in elderly patients with RAS- and BRAF wild-type metastatic colorectal cancer. Results of the multicenter phase II trial SAKK 41/10

Autor:	Christiane Pilop, Daniel Horber, D. Koeberle, Daniela Baertschi, R. von Moos, D. Kienle, D. Helbling, Marc Kueng, Sara Bastian, Daniel Dietrich, Piercarlo Saletti, Ralph Winterhalder
Rok vydání:	2015
Předmět:	Oncology Cancer Research medicine.medical_specialty Cetuximab Colorectal cancer business.industry Wild type medicine.disease First line treatment Capecitabine Internal medicine medicine business medicine.drug
Zdroj:	European Journal of Cancer. 51:S194-S195
ISSN:	0959-8049
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::a175251678b4adc86ed7f099de2be3d6 https://doi.org/10.1016/s0959-8049(16)30565-2 Zobrazit plný text záznamu Full Text from ScienceDirect